Study Stopped
PI left institution prior to receiving funding
Prediction of NEC With Urinary iFABP
An Assessment of Urinary Intestinal Fatty Acid Binding Protein as a Early Predictor of Necrotizing Enterocolitis
1 other identifier
interventional
N/A
1 country
1
Brief Summary
During the first four days of life, intestinal fatty acid binding protein (iFABP) is elevated in the urine of premature babies who go on to develop necrotizing enterocolitis (NEC) days to weeks later. This study aims to determine whether the withholding of feedings in babies with an elevated urinary iFABP can reduce the incidence of NEC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2013
CompletedFirst Posted
Study publicly available on registry
March 6, 2013
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedMay 14, 2015
May 1, 2015
1.7 years
March 4, 2013
May 13, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of necrotizing enterocolitis
90 days
Secondary Outcomes (1)
Time to caloric goal for enteral feedings
90 days
Study Arms (1)
iFABP Monitored
EXPERIMENTALSubjects monitored for urinary iFABP content during the first 4-12 days of life. Enteral feedings administered when iFABP levels are normal during the first four days of life or, if elevated during the first four days of life, have normalized for five days.
Interventions
Eligibility Criteria
You may qualify if:
- Gestational age less than 33 weeks
- Admission to Loma Linda University Children's Hospital NICU within 48 hours of life
You may not qualify if:
- Anuria
- Congenital gastrointestinal anomaly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loma Linda University Children's Hospital
Loma Linda, California, 92354, United States
Related Publications (2)
Mannoia K, Boskovic DS, Slater L, Plank MS, Angeles DM, Gollin G. Necrotizing enterocolitis is associated with neonatal intestinal injury. J Pediatr Surg. 2011 Jan;46(1):81-5. doi: 10.1016/j.jpedsurg.2010.09.069.
PMID: 21238645BACKGROUNDStadie D, Boskovic DS, Plank MS, et al. Elevated urinary intestinal fatty acid binding protein precedes clinical indicators of necrotizing enterocolitis. JSR 179:319, 2013.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gerald Gollin, MD
Loma Linda University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2013
First Posted
March 6, 2013
Study Start
November 1, 2014
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
May 14, 2015
Record last verified: 2015-05